Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activityLing Li, Jingxuan Chen, Huiting Zhao et al.|Bioorganic Chemistry|2021Cited by 40
Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screeningLing Li, Jianjun Chen, Junli Huang et al.|European Journal of Medicinal Chemistry|2022Cited by 29
Corrigendum to “Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity” [Bioorgan. Chem. 117 (2021) 105447]Ling Li, Chenglong Xu, Yinrong Wu et al.|Bioorganic Chemistry|2024Cited by 0